Strides gets FDA nod for tension headache pills
Strides Pharma Science Ltd. on Tuesday said its step-down wholly owned subsidiary, Strides Pharma Global Pte. Ltd., Singapore, had received approval from the United States Food and Drug Administration for Butalbital, Acetaminophen, and Caffeine tablets USP, in strengths of 50 mg/325 mg/40 mg, indicated for relief of “symptom complex of tension headache”.
You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in
Start your 14 days free trial. Sign Up
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Move smoothly between articles as our pages load instantly.
Enjoy reading as many articles as you wish without any limitations.
A one-stop-shop for seeing the latest updates, and managing your preferences.
A select list of articles that match your interests and tastes.
We brief you on the latest and most important developments, three times a day.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
Dear reader,
We have been keeping you up-to-date with information on the developments in India and the world that have a bearing on our health and wellbeing, our lives and livelihoods, during these difficult times. To enable wide dissemination of news that is in public interest, we have increased the number of articles that can be read free, and extended free trial periods. However, we have a request for those who can afford to subscribe: please do. As we fight disinformation and misinformation, and keep apace with the happenings, we need to commit greater resources to news gathering operations. We promise to deliver quality journalism that stays away from vested interest and political propaganda.
Support Quality JournalismDear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
Please enter a valid email address.
Printable version | Sep 22, 2020 11:04:37 PM | https://www.thehindu.com/business/strides-receives-usfda-approval-for-its-tablets/article32672233.ece
© THG PUBLISHING PVT LTD.